BioMed Research International / 2019 / Article / Tab 4 / Research Article
Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function AUC 95% CI P valueCys C cutoff (mg/L) Sensitivity Specificity Youden index CRP > 5 μ g/mL 0.793 (0.749–0.837) <0.001 0.85 0.782 0.719 0.501 BNP > 100 pg/mL 0.658 (0.605–0.712) <0.001 1.02 0.464 0.811 0.275 Killip class > 1 0.774 (0.727–0.822) <0.001 0.93 0.722 0.742 0.465 Multivessel disease 0.887 (0.858–0.919) <0.001 0.91 0.751 0.887 0.638 SYNTAX score ≥ 23 0.798 (0.741–0.854) <0.001 0.99 0.754 0.748 0.502 GRACE score ≥ 89 0.781 (0.737–0.826) <0.001 0.90 0.672 0.786 0.457 MetS 0.627 (0.569–0.685) <0.001 1.01 0.440 0.757 0.197 MACEs 0.723 (0.664–0.783) <0.001 0.87 0.816 0.497 0.313 Cardiac death 0.703 (0.595–0.811) 0.006 0.89 0.875 0.485 0.360 Non-fatal MI 0.676 (0.558–0.793) 0.008 1.03 0.550 0.736 0.286 TVR 0.699 (0.609–0.790) 0.001 0.82 0.958 0.369 0.328 Heart failure 0.708 (0.567–0.848) 0.019 0.96 0.727 0.630 0.357
Abbreviations. Cys C: cystatin C; CRP: C-reaction protein; BNP: B-type natriuretic peptide; MetS: metabolic syndrome; MACEs: major adverse cardiovascular events; MI: myocardial infarction; TVR: target vessel revascularization.